Evaluating the effects of empagliflozin in preventing myocardial injury in patients undergoing percutaneous coronary intervention: A double-blind, randomized clinical trial

Hossein Behzad ¹ , Sina Mashayekhi ², Hila Asham ¹, Parvin Sarbakhsh ³, Taher Entezari-Maleki ^1,2 *

Cited by CrossRef:

1- Rastgoo R, Yousefi Ramandi M, Ebrahimi F, Madadi R, Khederlou H, Ramazani A. Impact of Empagliflozin on mRNA Levels of Cardiotrophin-1 and GDF-15 in Patients with Type 2 Diabetes and ST-Segment Elevation Myocardial Infarction Undergoing PCI: A Double-Blind Pilot Trial. J Cardiovasc Thorac Res. 2026;18(2):116 [Crossref]

Platinum Open Access

This Platinum Open Access journal publishes articles totally free of charge for the authors and provides unrestricted access to the published content through its website and open access repositories such as PubMed Central. All related costs for processing of the manuscripts are sponsored by Tabriz University of Medical Sciences.

Indexing Info